173 354

Cited 0 times in

요통에 대한 NeurotropinⓇ 투여의 진통효과 및 안전성 평가를 위한 다기관, 이중맹검, Aceclofenac 비교 임상시험

Other Titles
 A Multi-center, Double-blind, Randomized and Comparative Clinical Study for the Safety and Analgesic Effect after four-week-treatment with NeurotropinⓇ in Patients with Low Back Pain: Compared to Aceclofenac 
Authors
 이환모  ;  문성환  ;  박시영  ;  김학선  ;  박희완  ;  주종환 
Citation
 Journal of Korean Society of Spine Surgery (대한척추외과학회지), Vol.12(3) : 214-223, 2005 
Journal Title
 Journal of Korean Society of Spine Surgery (대한척추외과학회지) 
ISSN
 1229-5701 
Issue Date
2005
MeSH
Low back pain ; Neurotropin ; Efficacy ; Safety
Keywords
Low back pain ; Neurotropin ; Efficacy ; Safety
Abstract
Study Design: A Multicenter double-blind randomized clinical study comparing Neurotropin and Aceclofenac. Objective: To evaluate the analgesic effect, efficacy and safety of Neurotropin in patients with low back pain. Summary of Literature Review: Non steroidal anti inflammatory analgesics are used as the main medical treatment in patients with low back pain. However, complications, such as gastrointestinal or cardiovascular problems, have been well documented. Neurotropin acts to recover the analgesic state arising from a decrease in pain threshold and has a completely different mechanism to that of existing anti-inflammatory and narcotic analgesics, with its action of restoring the immune system having been confirmed. Materials & Method: 376 patients with back pain were randomly divided into two groups; one group was administered Neurotropin and the other Aceclofenac. The overall improvement after 4 weeks was used as the first efficacy variable, and with the second efficacy variable the improvements in spontaneous pain, tenderness, motion pain, radiating pain, severity, pain intensity, and the overall severity and Oswestry Disability Indices were used as the evaluation criteria. To evaluate safety, the abnormal clinical response and alternations on physical examination and the clinical laboratory values were used. Results: A total of 358 patients received the experimental and comparison drugs, of which 351 were evaluated for safety. The overall improvement after 4 weeks, severity of symptoms, overall severity, and the pain intensity and Oswestry Disability Indices were decreased in both groups, but the differences between the two groups were not statistically significant. The overall decrease in the severity was greater in the Aceclofenac group, but both groups had statistically meaningful decreases after the administration of the drugs. i.e. Adverse drug reactions were less in the Neurotropin group, but these showed no significant statistical difference. Conclusions: Neurotropin and Aceclofenac are equally effective in patients with low back pain, but in terms of safety from a clinical view point Neurotropin is more reliable.
Files in This Item:
T200500730.pdf Download
DOI
10.4184/jkss.2005.12.3.214
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Orthopedic Surgery (정형외과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Hak Sun(김학선) ORCID logo https://orcid.org/0000-0002-8330-4688
Moon, Seong Hwan(문성환)
Park, Si Young(박시영)
Park, Hui Wan(박희완)
Lee, Hwan Mo(이환모) ORCID logo https://orcid.org/0000-0002-5405-3832
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/151027
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links